Cancer Topics Index 04/25/2016(Daily Test version/ 日刊テスト版)No.16

Cancer Topics Index 04/25/2016(Daily Test version/ 日刊テスト版) No.16

Flags 【海外:overseas】
◇NIH (National Institutes of Health)◇
Francis S Collins
Statement on NIH Clinical Center Improvement Plan (April 21, 2016 Francis S. Collins, M.D., Ph.D./Director, National Institutes of Health)

21 studies found for: cancer | received from 04/09/2016 to 04/11/2016

1 Recruiting
A Comparison Laparoscopic With Open Gastric Cancer Surgery for Locally Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Procedure: Laparoscopic procedures; Procedure: Open Surgery
Sponsor:Moscow Clinical Scientific Center
ClinicalTrials.gov Identifier:NCT02748551

2 Not yet recruiting
Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor
Condition: Metastatic Breast Cancer
Interventions: Drug: Palbociclib; Drug: Fulvestrant
Sponsor:Sidney Kimmel Comprehensive Cancer Center
ClinicalTrials.gov Identifier:NCT02738866

3 Not yet recruiting
Efficacy of Colonoscopy, Colon Capsule and Fecal Immunological Test for Colorectal Cancer Screening
Condition: Colon Cancer
Intervention: Other: colonoscopy colon capsule and FIT
Sponsor:Hôpital Edouard Herriot
ClinicalTrials.gov Identifier:NCT02738359

4 Not yet recruiting
Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer
Conditions: Ascites; Ovarian Epithelial Cancer; Malnutrition
Interventions: Device: Systematic ascites evacuation; Procedure: Acute paracentesis.; Behavioral: Interview.; Behavioral: Quality of life.; Behavioral: Nutritional status.
Sponsor:Gdynia Oncology Center
ClinicalTrials.gov Identifier:NCT02742428

5 Not yet recruiting
Feasibility and Safety Study of Prostate Stem Cell Antigen (PSCA)-Specific CAR T Cells In Subjects With Non-Resectable Pancreatic Cancer
Condition: Non-Resectable Pancreatic Cancer
Interventions: Biological: BPX-601; Drug: Rimiducid
Sponsor:Bellicum Pharmaceuticals
ClinicalTrials.gov Identifier:NCT02744287

6 Not yet recruiting
Pharmacist's Influence on Breast Cancer Patient Quality of Life
Condition: "Breast Cancer", "Quality of Life"
Intervention: Behavioral: Pharmacist's behavioral intervention
Sponsor:University Hospital "Sestre milosrdnice"
ClinicalTrials.gov Identifier:NCT02746666

7 Not yet recruiting
Near-infrared Image Guided Surgery in Pancreatic Adenocarcinoma
Conditions: Pancreatic Cancer; Pancreatic Adenocarcinoma
Intervention: Drug: Bevacizumab-800CW
Sponsor:University Medical Center Groningen
ClinicalTrials.gov Identifier:NCT02743975

8 Enrolling by invitation
Retrospective Epidemiological Study of Lung Cancer With Low-dose Multislice Computed Tomography
Condition: Lung Cancer
Sponsor:National Taiwan University Hospital
ClinicalTrials.gov Identifier:NCT02736643

9 Recruiting
Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)
Condition: Prostate Cancer
Interventions: Drug: Bicalutamide; Drug: goserelin acetate; Drug: flutamide; Drug: leuprolide acetate; Drug: triptorelin; Procedure: Definitive Treatment
Sponsor:Fudan University
ClinicalTrials.gov Identifier:NCT02742675

10 Not yet recruiting
Cryotherapy Combine Icotinib for Advanced NSCLC Treatment
Condition: Lung Neoplasms
Interventions: Procedure: Cryotherapy; Drug: Icotinib
Sponsor:Fuda Cancer Hospital, Guangzhou
ClinicalTrials.gov Identifier:NCT02744664

11 Not yet recruiting
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Conditions: Cancer; Venous Thromboembolism; Deep Vein Thrombosis (DVT); Pulmonary Embolism (PE); Blood Clot
Interventions: Drug: Rivaroxaban; Drug: Apixaban; Drug: Edoxaban; Drug: Dabigatran; Drug: Warfarin; Drug: Dalteparin; Drug: Enoxaparin; Drug: Fondaparinux
Sponsor:Alliance Foundation Trials, LLC.
ClinicalTrials.gov Identifier:NCT02744092

12 Not yet recruiting
Dose Finding Study Evaluating Safety and Feasibility in Patients With Relapsed or Refractory Myeloid Neoplasms
Conditions: Myeloid Neoplasms; Relapsed; Myelodysplastic Syndrome
Interventions: Biological: BPX-701; Drug: Rimiducid
Sponsor:Bellicum Pharmaceuticals
ClinicalTrials.gov Identifier:NCT02743611

13 Recruiting
Laser Therapy for the Prevention of Radiodermatitis in Head and Neck Patients
Conditions: Head Cancer; Neck Cancer
Interventions: Device: Low-level laser therapy; Device: sham laser
Sponsor:Hasselt University
ClinicalTrials.gov Identifier:NCT02738268

14 Not yet recruiting
Neoadjuvant Pembrolizumab for Muscle-invasive Urothelial Bladder Carcinoma
Condition: Urothelial Bladder Carcinoma
Intervention: Drug: Pembrolizumab (MK-3475)
Sponsor:Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
ClinicalTrials.gov Identifier:NCT02736266

15 Recruiting
A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 by Advanced Melanoma Subjects
Condition: Neoplasm
Intervention: Biological: SHR-1210
Sponsor:Jiangsu HengRui Medicine Co., Ltd.
ClinicalTrials.gov Identifier:NCT02738489

16 Not yet recruiting
Immune Predictors of Response to Pembrolizumab Therapy in Stage IV Melanoma Patients
Condition: Stage IV Melanoma
Sponsor:Mayo Clinic
ClinicalTrials.gov Identifier:NCT02744209

【AL アミロイドーシス】
17 Recruiting
A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early
Conditions: Plasma Cell Dyscrasia; Monoclonal Gammopathy
Sponsor:Tufts Medical Center
ClinicalTrials.gov Identifier:NCT02741999

19 Not yet recruiting
D-ALBA Front-Line Sequential Treatment of Adult Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia With Dasatinib and Blinatumomab
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Dasatinib; Drug: Blinatumomab
Sponsor:Gruppo Italiano Malattie EMatologiche dell'Adulto
ClinicalTrials.gov Identifier:NCT02744768

20 Not yet recruiting
Evaluate the Efficacy and Safety of TGR-1202 in Patients With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: TGR-1202
Sponsor:TG Therapeutics, Inc.
ClinicalTrials.gov Identifier:NCT02742090

21 Not yet recruiting
Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma
Conditions: Adult T-cell Leukemia-Lymphoma; ATLL
Interventions: Drug: Belinostat; Drug: Zidovudine; Drug: Interferon-Alfa-2b; Drug: Pegylated Interferon-Alfa-2b
Sponsor:University of Miami
ClinicalTrials.gov Identifier:NCT02737046

<Pharmaceuticals and Medical Devices>
First Presentation of Overall Survival Data for Opdivo® (nivolumab) Shows Significant Survival Benefit at One-Year Versus Investigator’s Choice in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (April 19, 2016 BMS)
再発または転移性頭頸部扁平上皮がんにおけるオプジーボ®(一般名:ニボルマブ)の全生存期間データが初めて発表され、治験担当医師が選択した治療と比較して、1 年時点で有意な生存ベネフィットを示す (04/21/2016 ブリストル・マイヤーズ スクイブ Bristol-Myers Squibb/小野薬品工業 ONO PHARMACEUTICAL) pdf

First Presentation of Two-Year Overall Survival Data for Opdivo® (nivolumab) in Combination with Yervoy® (ipilimumab) Showed Superior Efficacy Versus Yervoy Alone in Advanced Melanoma (April 17, 2016 BMS)
進行期悪性黒色腫におけるオプジーボ®(一般名:ニボルマブ)とヤーボイ®(一般名:イピリムマブ)併用療法の 2 年の全生存期間データが初めて発表され、ヤーボイ単剤療法と比較して優れた有効性を示す (04/22/2016 ブリストル・マイヤーズ スクイブ Bristol-Myers Squibb/小野薬品工業 ONO PHARMACEUTICAL) pdf

Merck and Pfizer Announce First Patient Treated in Phase III Combination Study with Avelumab and INLYTA® in Renal Cell Carcinoma (April 5, 2016 Merck)
独メルク社と米ファイザー社、腎細胞がんを対象としてavelumabとインライタ®の併用投与を検討する第Ⅲ相試験を開始 (04/21/2016 ファイザー Pfizer)

<Medical Journal & Other News>
Cell death mechanism may -- paradoxically -- enable aggressive pancreatic cells to live on (04/22/2016 EurekAlert!/NYU LANGONE MEDICAL CENTER / NEW YORK UNIVERSITY SCHOOL OF MEDICINE)

【神経膠腫/制御性T細胞】JOURNAL:JCI Insight
Critical immunotherapy target marks dysfunctional regulatory T cells in brain cancer (04/21/2016 EurekAlert!/JOURNAL OF CLINICAL INVESTIGATION)

Graphics 【日本国内:Japan】
<Press Release:日本国内>
特定高速電子計算機施設(スーパーコンピュータ「京」)に係る評価委員会(第2回) 配付資料 (04/22/2016文部科学省:MEXT)
HPCI戦略プログラム 分野1予測する生命科学・医療および創薬基盤 (平成28年3月9日 国立研究開発法人 理化学研究所) pdf

福島・見捨てられた甲状腺がん患者の怒り (04/24/3016 女性自身)

闘病記古書店の星野史雄さん逝く NPOが蔵書引き継ぐ (04/23/2016 朝日新聞デジタル)
<記事を追跡:Follow-up story>
「闘病記おたくの闘病記」星野史雄さんインタビュー(1)(YouTube 4:46 2015/10/26)
「闘病記おたくの闘病記」星野史雄さんインタビュー(2)(YouTube 4:53 2015/10/26)

子宮頸がんワクチン「接種を推奨」=17学術団体が見解 (04/23/2016 時事.com)

がん患者が嬉しい言葉、つらい言葉 命を紡ぐ 現場の声【3】(04/23/2016 PRESIDENTOnline)

三重大 ワクチンなどがん免疫3療法組み合わせ 来年度から治験 (04/22/2016 化学工業日報)
<記事を追跡:Follow-up story>
三重大学複合的がん免疫療法センター (web)

ゲノム編集 ヒト受精卵改変を一部容認…臨床利用は認めず (04/22/2016 毎日新聞)

がん患者こそポジティブに 知っておきたい「3つの事実」聖路加国際病院精神腫瘍科部長 保坂隆医師(04/22/2016 日刊ゲンダイ)

<新刊メタデータ:New Books>
【タイトル】ホスピス緩和ケア白書 2016
編集:志真 泰夫, 恒藤 暁, 森田 達也, 宮下 光令/単行本: 117ページ/出版社: 青海社 (2016/4/18)/ISBN-10: 4902249812/ISBN-13: 978-4902249811/¥2,376

【タイトル】StepUPがん検査:講義と試験でマスター (DVD-ROM付)
著者:国立病院関東甲信越放射線技師会政策医療班『消化器班・超音波班』/単行本(ソフトカバー): 196ページ/出版社: 医療科学社 (2016/4/22)/ISBN-10: 4860034767/ISBN-13: 978-4860034764/¥5,184

<雑誌記事:Magazine/Medical journal>
Stockholm Public Library
◆日経マネー (2016年6月号)/日経BP出版センター/発売日:2016年4月21日/価格(税込):730円
【タイトル】特集3 働き続けるための処方箋
・がん、介護者になっても辞めない 働き続けるための処方箋
・がん退職 思い込みが招く安易な退職 治療費より生活費が問題に
・イメージに惑わされるな 働き続けるがん患者は多い
・介護離職 福祉サービスのフル活用で介護と仕事は両立できる!